Trial Profile

Open Label Exploratory Study to Evaluate the Effect of Dupilumab on Skin Barrier Function in Patients With Moderate to Severe Atopic Dermatitis

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

21 Mar 2023 Results assessing the effects of dupilumab on skin barrier function in patients with AD presented at the American Academy of Dermatology annual Meeting 2023
21 Mar 2023 Results assessing the effects of dupilumab on vascular barrier function in patients with moderate-to-severe AD presented at the American Academy of Dermatology annual Meeting 2023
11 Jul 2022 Results assessing the content of lipids and transepidermal water loss in lesional and non-lesional skin of adults and adolescents with moderate-to-severe AD over the course of 16-week treatment with dupilumab and compared those values with that of matched healthy volunteers, published in the Allergy.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com